Historique
![MDMB-4en-PINACA. Risk Assessment Report on a new psychoactive substance: methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-car- bonyl]amino}butanoate (MDMB-4en-PINACA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_84047.webp?v=1771256016)
Rapport
MDMB-4en-PINACA. Risk Assessment Report on a new psychoactive substance: methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-car- bonyl]amino}butanoate (MDMB-4en-PINACA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended)
Auteur(s) :
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction)
Année
2021
Page(s) :
22 p.
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : OEDT / EMCDDA
Collection :
Risk assessments
Domaine :
Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Organismes
OEDT
Thésaurus mots-clés
CONTROLE DES STUPEFIANTS
;
PHARMACOLOGIE
;
FACTEUR DE RISQUE
;
TOXICOLOGIE
;
DROGUES DE SYNTHESE
;
REGLEMENTATION
;
CANNABINOIDES
;
AGONISTE
;
CHIMIE
;
TOXICITE
Note de contenu :
TABLE OF CONTENTS:
- Statement regarding the United Kingdom
- Contents
- Introduction
- Background
- Pharmacological and toxicological properties
- Health risks
- Social risks
- Extent and patterns of use, availability and potential for diffusion
- Commercial and industrial uses, the extent of such use and its use for scientific research and developmental purposes
- Other relevant information
- Conclusion
- Statement regarding the United Kingdom
- Contents
- Introduction
- Background
- Pharmacological and toxicological properties
- Health risks
- Social risks
- Extent and patterns of use, availability and potential for diffusion
- Commercial and industrial uses, the extent of such use and its use for scientific research and developmental purposes
- Other relevant information
- Conclusion
Résumé :
This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on MDMB-4en-PINACA. The report is intended for policymakers and decision-makers in the institutions of the EU.